Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial88

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial38

Views

Views
April 20254
May 20259
June 20252
July 202516
August 20252
September 20255
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Brazil11
United Kingdom3
Austria1
Canada1
Spain1
Italy1
Kenya1
 

Top cities views

Views
Fort Lee3
Araputanga1
Bragança Paulista1
Brooklyn1
Calgary1
Council Bluffs1
Dallas1
Florianópolis1
Goiânia1
Hamilton1